Potential markers for alzheimer's disease: Plasma p-tau181/Aβ1-42 Dr. Nandita Mohan28 March 2022 6:30 PM ISTAlzheimer's disease is thought to be caused by the abnormal build-up of proteins in and around brain cells. One of the proteins involved is called...
Physical fitness linked to lower risk of Alzheimer's disease Hina Zahid19 March 2022 9:00 AM ISTMINNEAPOLIS - People who are more physically fit are less likely to develop Alzheimer's disease than people who are less physically fit, according to...
Exercise to reduce the risk of Alzheimer's disease Dr. Nandita Mohan14 March 2022 3:45 PM ISTFrequent and regular physical exercise is an important component in the prevention of some diseases such as heart disease, cardiovascular disease,...
12/March/2022 Top Medical Bulletin Dr. Nandita Mohan12 March 2022 7:00 PM ISTHere are top medical stories for today: Home blood pressure reading more accurate than one taken at clinicBlood pressure...
Estrogen might be protective against brain shrinkage Dr. Nandita Mohan7 Feb 2022 5:58 PM ISTEstrogens reportedly is known to affect the development and aging of brain regions that are crucial to higher cognitive functions (like memory)...
Maintaining Oral Health Might Benefits Alzheimer's Patients MD Bureau10 Jan 2022 9:00 AM ISTAlzheimer`s disease (AD) is the most common cause of dementia in the elderly age group and a major health problem in the geriatric population...
MRI may detect Concussion-Linked CTE while Patients are still alive MD Editorial Team11 Dec 2021 9:00 AM ISTChronic traumatic encephalopathy (CTE), a neurodegenerative tauopathy, cannot be diagnosed during life at the moment. Atrophy patterns on magnetic...
Drug designed for Alzheimer's disease holds promise for treating glioblastoma Hina Zahid27 Nov 2021 9:00 AM ISTCLEVELAND - New Cleveland Clinic research found that drugs originally designed to help treat Alzheimer's disease may hold promise for glioblastoma,...
Losartan fails to slow down progression of more advanced Alzheimer's, Lancet study finds Hina Zahid20 Nov 2021 9:00 AM ISTCommon blood pressure drug Losartan, did not reduce rate of brain atrophy in clinically diagnosed mild-to-moderate Alzheimer's disease, finds a new...
Alzheimer's drug price will be competitive: Roche executive Ruchika Sharma13 Nov 2021 10:00 AM ISTNew Delhi: Roche Holding AG, still months away from seeking regulatory approval of its experimental Alzheimer's drug, is already taking aim at rival...
Baseline MRI atrophy may predict 2-year cognitive outcomes in early-onset Alzheimer's disease: Study Medha Baranwal27 Oct 2021 9:00 AM ISTSpain: A recent study has reported that baseline MRI findings can predict two-year cognitive outcomes in patients with early-onset Alzheimer's disease...
Diuretic Bumetanide may be potential candidate for Alzheimer's treatment Hina Zahid22 Oct 2021 9:00 AM ISTDiuretic bumetanide may be a potential candidate for an Alzheimer's disease treatment for those who are at genetic risk, according to findings...
